Growth Horm IGF Res 18:434438 Lordereau-Richard I, Roger M, Chaussain JL (1994) Transient bilateral papilloedema in a 10-year-old boy treated with recombinant insulin-like growth factor I for growth hormone receptor deficiency
04:55 Dr
Common gastrointestinal side effects: The most frequently reported adverse effects are gastrointestinal in nature, occurring in up to 40-80% of patients with higher doses, particularly during dose escalation: [13] [14] Nausea (most common, typically improves after 4-8 weeks) Vomiting Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite These effects can be minimised by starting with low doses and gradually titrating upwards according to manufacturer guidance
The bottom line Earlier GLP-1s were game-changers, but 10% to 15% of people don't lose weight on them
however, no patients reached an HbA1c less than 7%
Whether youre just starting your research or already considering treatment, understanding what you're putting into your body is a crucial part of the journey